Market research
EAST.V EastWest Bioscience Inc
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3M
- P/E ratio
- 0.02
- Analyst target
- 461.63
- Dividend yield
- 0.0%
- Beta
- 0.7
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA27783V1076
- Market cap
- 3M
- P/E ratio
- 0.02
- Analyst target
- 461.63
- Dividend yield
- 0.0%
- Beta
- 0.7
About
About EastWest Bioscience Inc
EastWest Bioscience Inc., a vertically-integrated wellness company, engages in the manufacturing and sale of hemp nutritional products in Canada and the United States. The company also operates Sangster's Health Center stores that sells supplements and wellness products through its franchise locations and online ecommerce platform. In addition, it is involved in the property management business. The company was founded in 2016 and is headquartered in Penticton, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the EAST.V discussion.
5 years, 5 months ago
EastWest Bioscience Inc is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
EastWest Bioscience Inc's total revenue sank by 35.8% to $172K since the same quarter in the previous year.
Its net income has dropped by 638.8% to $-311K since the same quarter in the previous year.
Finally, its free cash flow fell by 285.8% to $-197K since the same quarter in the previous year.
Based on the above factors, EastWest Bioscience Inc gets an overall score of 1/5.